The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Results

25 Nov 2022 09:30

RNS Number : 6243H
British Smaller Companies VCT2 Plc
25 November 2022
 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 30 September 2022

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 30 September 2022. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company's Total Return at 30 September 2022 was unchanged at 139.8 pence per ordinary share. During the same period the FTSE Small Cap fell by 5.7 per cent.

Four follow-on investments were made in the period, into Vypr, Force24, Vuealta and Wooshii, totalling £2.4 million.

Following the quarter end, two new investments and two follow-on investments totalling £4.7 million have been completed, taking the total invested in the current financial year to £12.8 million, following the £6.1 million invested in the whole of the previous year.

Realisations in the period

During the period, the Company realised its investments in Springboard and Intelligent Office, generating total proceeds of £9.9 million in the period, realising a gain of £0.5 million over the opening carrying value and £4.2 million over the original cost.

The realisation of Springboard generated proceeds of £5.8 million, representing a capital profit over cost of £3.9 million, an uplift of 46.0 per cent or £1.8 million on the carrying value at the beginning of the year. Including income, the total return from this investment was £6.6 million over a near eight year holding period, producing an internal rate of return of 23 per cent and a multiple of 4.1x cost. There is the prospect of further consideration in 2023 based on performance targets; however, no value has been recognised relating to these potential payments at this time.

The sale of Intelligent Office generated proceeds of £4.1 million, representing a capital profit over cost of £2.1 million and an uplift of 29.0 per cent, or £0.9 million, on the carrying value at the beginning of the year. Including income, the total return from this investment was £5.0 million over an eight and a half year holding period, producing an internal rate of return of 14 per cent and a multiple of 2.6x cost.

 

Performance

The movement in Total Return in pence per ordinary share is set out in the table below:

 

30 June 2022

Decrease in Value

Buyback of shares

Movement

In Period

30 September 2022

Net Assets (£m)

109.6

(0.1)

(0.3)

(0.4)

109.2

NAV per share (PPS)

60.3p

-

-

-

60.3p

Cumulative dividends paid (PPS)

79.5p

-

-

-

79.5p

Total Return (PPS)

139.8p

-

-

-

139.8p

Shares in issue

181,720,724

-

(556,386)

(556,386)

181,164,338

The unaudited NAV per ordinary share was unchanged at 60.3 pence per share (30 June 2022: 60.3 pence per ordinary share).

The movements in NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 30 June 2022

109.6

60.3

Increase in portfolio value

0.3

0.2

Net operating costs

(0.4)

(0.2)

Buy-back of shares

(0.3)

-

 

(0.4)

-

NAV at 30 September 2022

 

109.2

 

60.3

 

Following payment of the second interim dividend of 1.5 pence per ordinary share for the year ending 31 December 2022 on 3 October 2022, the unaudited net asset value is 58.8 pence per ordinary share.

Dividends and shares in issue

On 27 September 2022, the Company purchased 556,386 ordinary shares of 10 pence each at a price of 56.36 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 30 September 2022 was 181,164,338 (30 June 2022: 181,720,724). In addition, at 30 September 2022 the Company held 18,048,870 ordinary shares in treasury (30 June 2022: 17,492,484)

Following payment of the second interim dividend for the year ending 31 December 2022 of 1.5 pence per ordinary share on 3 October 2022, the Company issued 922,314 ordinary shares under the DRIS, taking cumulative dividends paid to 81.0 pence per ordinary share and the number of ordinary shares in issue to 182,086,652 at that date.

The Board has approved a special dividend of 2.25 pence per ordinary share which will be paid on 11 January 2023 to those shareholders on the Company's register at the close of business on 18 November 2022. The payment of the special dividend follows the successful exits from the investments in Springboard and Intelligent Office noted above.

Net assets

Net assets at 30 September 2022 comprised the following:

£000

% of net assets

Unquoted investments at fair value

71,038

65.0

Listed investment funds

1,326

1.2

Cash and cash equivalents

32,444

29.7

Other net current assets

4,414

4.1

Net assets

109,222

100.0

 

Investments

The investment portfolio at 30 September 2022 comprised:

Valuation

£000

Cumulative valuation as a % of net assets

Matillion

20,721

19.0%

Outpost

5,469

24.0%

Unbiased

4,330

27.9%

Displayplan

3,967

31.6%

Wooshii

3,652

34.9%

Force24

3,188

37.8%

ACC Aviation

3,147

40.7%

Elucidat

2,699

43.2%

SharpCloud

2,668

45.6%

Vypr

2,661

48.1%

52,502

48.1%

Other investments

18,536

65.0%

Total investments

71,038

65.0%

Shareholder relations

The online Shareholder Workshop will be held on Thursday 1 December 2022 at 11:00am.

Fundraising

On 2 August 2022, the Company announced its intention to launch a new joint offer for subscription for the tax year 2022-23 later this year, alongside British Smaller Companies VCT plc. A prospectus with full details of the proposed offer will be published on or around 30 November 2022.

Outlook

In the face of a challenging economic environment, portfolio companies are to date proving themselves to be adaptable and resilient. It is expected that in these testing times, demand for equity capital from the UK's smaller innovative businesses will increase. Such conditions often prove to be an opportune time to invest long term capital in fast growing businesses, and therefore the planned fundraising by the Company will ensure it is well placed to take advantage of new opportunities arising across the United Kingdom.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

25 November 2022

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTPPGMGGUPPUMA
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.